EG24462A - Compounds for treating fundic disaccomodation - Google Patents

Compounds for treating fundic disaccomodation

Info

Publication number
EG24462A
EG24462A EG20010661A EG20010661A EG24462A EG 24462 A EG24462 A EG 24462A EG 20010661 A EG20010661 A EG 20010661A EG 20010661 A EG20010661 A EG 20010661A EG 24462 A EG24462 A EG 24462A
Authority
EG
Egypt
Prior art keywords
disaccomodation
fundic
treating
compounds
treating fundic
Prior art date
Application number
EG20010661A
Other languages
English (en)
Inventor
Kristof Van Emelen
Marcel F De Bruyn
Manuel J Alcazar-Vaca
Jose I Andres-Gil
Francisco J Fernandez-Gadea
Maria E Matesanz-Ballesteros
Jose M Bartolome-Nebreda
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Application granted granted Critical
Publication of EG24462A publication Critical patent/EG24462A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D411/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D411/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D411/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
EG20010661A 2000-06-22 2001-06-20 Compounds for treating fundic disaccomodation EG24462A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00202180 2000-06-22

Publications (1)

Publication Number Publication Date
EG24462A true EG24462A (en) 2009-07-16

Family

ID=8171674

Family Applications (1)

Application Number Title Priority Date Filing Date
EG20010661A EG24462A (en) 2000-06-22 2001-06-20 Compounds for treating fundic disaccomodation

Country Status (33)

Country Link
US (2) US7081453B2 (cs)
EP (1) EP1296987B1 (cs)
JP (1) JP4911860B2 (cs)
KR (1) KR100821107B1 (cs)
CN (2) CN1288157C (cs)
AR (1) AR032158A1 (cs)
AT (1) ATE312104T1 (cs)
AU (1) AU783292B2 (cs)
BG (1) BG65895B1 (cs)
BR (1) BR0111859B1 (cs)
CA (1) CA2410233C (cs)
CZ (1) CZ305005B6 (cs)
DE (1) DE60115647T2 (cs)
EA (1) EA005760B1 (cs)
EE (1) EE04878B1 (cs)
EG (1) EG24462A (cs)
ES (1) ES2254467T3 (cs)
HR (1) HRP20020988B1 (cs)
HU (1) HU227398B1 (cs)
IL (2) IL153559A0 (cs)
IS (1) IS2618B (cs)
JO (1) JO2352B1 (cs)
MX (1) MXPA02012844A (cs)
MY (1) MY155267A (cs)
NO (1) NO328547B1 (cs)
NZ (1) NZ522519A (cs)
PA (1) PA8519601A1 (cs)
PL (1) PL201656B1 (cs)
SA (1) SA01220442B1 (cs)
SK (1) SK287730B6 (cs)
UA (1) UA74576C2 (cs)
WO (1) WO2001098306A1 (cs)
ZA (1) ZA200210303B (cs)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EE04780B1 (et) * 1999-06-02 2007-02-15 Janssen Pharmaceutica N.V. Aminoalküül-asendatud bensodioksaani, bensofuraani või bensopüraani derivaadid, nende valmistamismeetod, farmatseutiline kompositsioon ja selle valmistamismeetod
SK286159B6 (sk) 1999-06-02 2008-04-07 Janssen Pharmaceutica N. V. Benzodioxánový, benzofuránový alebo benzopyránovýderivát, spôsob jeho prípravy, tento derivát na použitie ako liečivo, farmaceutická kompozícia obsahujúca tento derivát a spôsob jej prípravy
JO2352B1 (en) * 2000-06-22 2006-12-12 جانسين فارماسيوتيكا ان. في Compounds for the treatment of non-adaptation of the bottom of the uterus
JO2654B1 (en) * 2000-09-04 2012-06-17 شركة جانسين فارماسوتيكا ان. في Multiple aryl caroxa amides are useful as lipid - lowering agents
JO2409B1 (en) * 2000-11-21 2007-06-17 شركة جانسين فارماسوتيكا ان. في Second-phenyl carboxy amides are useful as lipid-lowering agents
EP1622569B1 (en) 2003-04-24 2015-12-02 Incyte Corporation Aza spiro alkane derivatives as inhibitors of metallproteases
JP4896476B2 (ja) * 2005-09-16 2012-03-14 広栄化学工業株式会社 メチルオキシメチルアミノピリジン誘導体及びその製造方法
US7999107B2 (en) 2007-01-31 2011-08-16 Merck Sharp & Dohme Corp. Substituted pyrano[2,3-B]pyridine derivatives as cannabinoid-1 receptor modulators
JP2010526825A (ja) * 2007-05-10 2010-08-05 エーエムアール テクノロジー インコーポレイテッド アリール置換およびヘテロアリール置換テトラヒドロベンゾ−１，４−ジアゼピンならびにノルエピネフリン、ドーパミンおよびセロトニンの再取り込みを遮断するためのその使用
CN103917529B (zh) 2011-11-11 2016-08-17 辉瑞大药厂 2-硫代嘧啶酮类
AU2016257179A1 (en) 2015-05-05 2017-11-02 Pfizer Inc. 2-thiopyrimidinones
CN105481839B (zh) * 2015-11-23 2018-05-11 安徽千和新材料科技发展有限公司 一种光活性环氧啉对映体的制备方法
EP3229193A1 (en) 2016-04-07 2017-10-11 The Boeing Company A computer-implemented method and system for sharing information between passengers and air traffic management stakeholders

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3910930A (en) * 1973-01-04 1975-10-07 Janssen Pharmaceutica Nv 1-{55 1-{8 2-(1,4-Benzodioxan-2-yl)-2-hydroxyethyl{9 -4-piperidyl{56 -2-benzimidazolinones
DE2400049A1 (de) * 1974-01-02 1975-07-10 Spumalit Anstalt Transportkasten aus kunststoff, insbesondere fuer flaschen
GR71865B (cs) * 1978-03-20 1983-07-07 Ciba Geigy
US4329348A (en) * 1979-02-26 1982-05-11 Ciba-Geigy Corporation N-Oxacyclic-alkylpiperidines as psychostimulants
DE3484096D1 (de) * 1983-11-30 1991-03-14 Janssen Pharmaceutica Nv Bizyklisches heterozyklyl aufveisende n-(bizyklisches heterozyklyl-4-piperidinamine.
SI9300097B (en) * 1992-02-27 2001-12-31 Janssen Pharmaceutica Nv (benzodioxan, benzofuran or benzopyran) alkylamino) alkyl substituted guanidines
ZA931343B (en) 1992-03-06 1993-09-24 Akzo Nv 1,4-dioxino(2,3-b)pyridine derivatives.
US6403103B1 (en) * 1994-08-12 2002-06-11 Bio Merieux Trypanosoma cruzi antigen, gene encoding therefore, and methods of detecting and treating chagas disease
FR2744451B1 (fr) * 1996-02-01 1998-04-24 Pf Medicament Nouvelles imidazolidinones, pyrimidinones, et 1,3-diazepin-2 -ones, leur preparation et leurs applications en therapeutique
US6133277A (en) * 1997-12-05 2000-10-17 Janssen Pharmaceutica N.V. (Benzodioxan, benzofuran or benzopyran) derivatives having fundic relaxation properties
EE04780B1 (et) * 1999-06-02 2007-02-15 Janssen Pharmaceutica N.V. Aminoalküül-asendatud bensodioksaani, bensofuraani või bensopüraani derivaadid, nende valmistamismeetod, farmatseutiline kompositsioon ja selle valmistamismeetod
SK286159B6 (sk) 1999-06-02 2008-04-07 Janssen Pharmaceutica N. V. Benzodioxánový, benzofuránový alebo benzopyránovýderivát, spôsob jeho prípravy, tento derivát na použitie ako liečivo, farmaceutická kompozícia obsahujúca tento derivát a spôsob jej prípravy
TWI225488B (en) * 1999-12-21 2004-12-21 Janssen Pharmaceutica Nv Derivatives of homopiperidinyl substituted benzimidazole analogues
JO2352B1 (en) * 2000-06-22 2006-12-12 جانسين فارماسيوتيكا ان. في Compounds for the treatment of non-adaptation of the bottom of the uterus

Also Published As

Publication number Publication date
WO2001098306A1 (en) 2001-12-27
HU227398B1 (hu) 2011-05-30
BR0111859A (pt) 2003-05-13
ZA200210303B (en) 2004-03-19
DE60115647T2 (de) 2006-08-24
MXPA02012844A (es) 2003-05-15
JP4911860B2 (ja) 2012-04-04
EE200200694A (et) 2004-06-15
BR0111859B1 (pt) 2015-01-06
US20060142318A1 (en) 2006-06-29
AU8386401A (en) 2002-01-02
AU783292B2 (en) 2005-10-13
BG65895B1 (bg) 2010-04-30
UA74576C2 (en) 2006-01-16
CN100516066C (zh) 2009-07-22
HUP0301185A3 (en) 2009-03-30
NO20026219D0 (no) 2002-12-23
BG107313A (bg) 2003-06-30
US20040019051A1 (en) 2004-01-29
IL153559A0 (en) 2003-07-06
PL358886A1 (en) 2004-08-23
AR032158A1 (es) 2003-10-29
SA01220442B1 (ar) 2008-05-21
HRP20020988A2 (en) 2005-02-28
PA8519601A1 (es) 2002-08-26
NO328547B1 (no) 2010-03-15
MY155267A (en) 2015-09-30
EA200300049A1 (ru) 2003-04-24
SK287730B6 (en) 2011-07-06
KR100821107B1 (ko) 2008-04-14
CN1437602A (zh) 2003-08-20
EA005760B1 (ru) 2005-06-30
HK1057896A1 (en) 2004-04-23
CZ2003115A3 (cs) 2003-06-18
ATE312104T1 (de) 2005-12-15
EP1296987B1 (en) 2005-12-07
JO2352B1 (en) 2006-12-12
KR20030007566A (ko) 2003-01-23
IS2618B (is) 2010-04-15
HUP0301185A2 (hu) 2003-08-28
IL153559A (en) 2008-03-20
JP2004501157A (ja) 2004-01-15
US7081453B2 (en) 2006-07-25
SK492003A3 (en) 2003-07-01
NO20026219L (no) 2003-02-17
US7423048B2 (en) 2008-09-09
CA2410233A1 (en) 2001-12-27
ES2254467T3 (es) 2006-06-16
CN1288157C (zh) 2006-12-06
CZ305005B6 (cs) 2015-03-25
IS6591A (is) 2002-10-25
HRP20020988B1 (en) 2011-06-30
NZ522519A (en) 2003-09-26
CN1781921A (zh) 2006-06-07
CA2410233C (en) 2011-01-25
EE04878B1 (et) 2007-08-15
PL201656B1 (pl) 2009-04-30
EP1296987A1 (en) 2003-04-02
DE60115647D1 (de) 2006-01-12

Similar Documents

Publication Publication Date Title
EP1349851A4 (en) COMPOUNDS
EG24462A (en) Compounds for treating fundic disaccomodation
AU2405002A (en) Dehalogeno compounds
GB0019950D0 (en) Compounds
AU1603401A (en) Pyranoindoles for treating glaucoma
GB0007652D0 (en) Treatment for fabrics
GB0007665D0 (en) Treatment for fabrics
GB0007653D0 (en) Compounds
GB0003637D0 (en) Compounds
GB0002969D0 (en) Compounds
GB0003140D0 (en) Compounds
GB0003598D0 (en) Compounds
GB0003599D0 (en) Compounds
GB0003600D0 (en) Compounds
GB0003608D0 (en) Compounds
GB0007404D0 (en) Compounds
GB0023193D0 (en) Compounds
GB0021531D0 (en) Compounds
GB0021492D0 (en) Compounds
GB0020503D0 (en) Compounds
GB0019578D0 (en) Polysulphamated compounds
GB0018351D0 (en) Compounds
GB0018306D0 (en) Compounds
GB0015902D0 (en) Compounds
GB0015863D0 (en) Compounds